Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “Stomach Diseases”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 19 recordsLinked to original sources
PubMed1996

A nucleolar RNA helicase recognized by autoimmune antibodies from a patient with watermelon stomach disease.

Watermelon stomach is characterized by prominent stripes of ectatic vascular tissue in the stomach similar to stripes on a watermelon; in patients with this disorder chronic gastrointestinal bleeding occurs and approximately half of these patients have associated autoimmune disorders. In the serum of one patient, an antinucleolar antibody titer of 1:25 600 was found; the antibodies specifically recognized an approximately 100 kDa nucleolar protein, which we referred to as the 'Gu' protein. Its cDNA was cloned and sequenced. The Gu protein is a member of a new subgroup of RNA helicases, the DEXD box family. Gu protein fused with glutathione S-transferase contains ATP-dependent RNA helicase activity which preferably translocates in the 5'-->3' direction. Its RNA folding activity, RNA-dependent ATPase and dATPase activities, and its translocation direction are similar to those of RNA helicase II [Flores-Rozas, H. and Hurwitz, J. (1993) J. Biol. Chem. 268, 21372-21383]. Sequencing of 209 amino acids of RNA helicase II peptides showed 96.7% identity with the cDNA-derived amino acid sequence of the Gu protein. The precise biological roles of this RNA helicase in the biogenesis of ribosomal RNA and the pathogenesis of watermelon disease and autoimmune disorder require further study.

Adenosine Triphosphatases↗
PubMed1978

Microbial flora of the diseased stomach at resection.

The relation of microbial flora in stomach contents and stomach wall was examined in paired specimens from 10 surgical patients and in specimens of wall from 10 additional patients. The flora of both contents and wall were similar. Paired specimens from five patients contained the same kinds of bacteria. Paired specimens from these patients were sterile. Contents from two patients contained bacteria, but the wall was sterile. Microorganisms isolated were streptococci, lactobacilli, bifidobacteria, bacteroides, staphylococci yeast, and coliforms. Bacterial counts ranged from 0 to 10(7.5) per ml or g in both contents and tissue. Survey of the literature shows that most specimens from patients with gastric ulcers or gastric malignancies are positive for bacteria, while only about 60% of specimens from patients with duodenal ulcers are positive.

Bacteria↗
PubMed1979

Fibrinolytic activity in gastric venous blood. A comparison between normal and diseased stomachs.

The fibrinolytic activity of blood draining from the stomachs of patients with gastroduodenal disease has been compared with the fibrinolytic activity of blood in the systemic venous circulation and with the blood draining from normal stomachs. Gastric venous blood from normal and diseased stomachs contains greater amounts of plasminogen activator than simultaneously sampled systemic venous blood. However, gastric venous fibrinolytic activity does not differ between the normal and diseased stomachs and thus indicates that increased gastric venous fibrinolysis is not just a characteristic of the diseased stomach. The studies suggest that stress may cause activation of the fibrinolytic system in gastric venous blood with the release of small amounts of free plasmin. It is postulated that local fibrinolysis may play a part in potentiating gastric hemorrhage.

Blood Cell Count↗
PubMed1999

Stomach diseases: MR evaluation using combined t2-weighted single-shot echo train spin-echo and gadolinium-enhanced spoiled gradient-echo sequences.

The aim of this study was to describe the magnetic resonance (MR) appearances of diseases of the stomach using combined T1-weighted spoiled gradient-echo, T2-weighted single-shot echo train spin-echo and gadolinium-enhanced spoiled gradient-echo sequences. All patients with gastric diseases who underwent combined T2-weighted single-shot echo train spin-echo and gadolinium-enhanced conventional and fat-suppressed spoiled gradient-echo imaging between October 1, 1996 and March 1, 1999, and who had histological or other imaging proof of disease, were included in this study. This patient population was comprised of 40 patients with subsequently proven gastric abnormalities, including malignant tumors (25) or benign disease (15). The MRI sequences included T1-weighted, T2-weighted, and early and late gadolinium-enhanced spoiled gradient-echo (SGE) images. Evaluation was made of the following parameters: a) the ability to detect the disease process on MRI, by comparing the original prospective MR reports with the records of the pathology department; b) the MR appearance of a variety of gastric diseases; and c) the sequences that most clearly demonstrated abnormalities by retrospective review of the MR studies. MR images demonstrated 22 of 25 malignant tumors. Evaluation of the extent of the tumor was correctly shown in 22 of 25 tumors. Small-volume tumor (one patient with gastric adenocarcinoma, and one patient with lymphoma) and coexistent infiltrative adenocarcinoma and gastritis (one patient) rendered demonstration of tumor poor on MR images in three patients. Tumors were mildly hypointense on T1-weighted images and mildly hyperintense on T2-weighted images. Tumors enhanced in a heterogeneous fashion compared with background stomach wall, but they ranged from hypointense to hyperintense on early and late post-gadolinium SGE images. Regarding benign diseases, the changes of gastritis were evident in three of four cases. Gastritis appeared as increased mucosal enhancement that ranged from moderate to intense on early and late post-gadolinium SGE images. Imaging findings of the various entities are described in greater detail in the text. MR findings in a variety of neoplastic and non-neoplastic diseases of the stomach are described. Neoplastic diseases were consistently observed in most cases; however, small tumors and tumors coexistent with inflammatory changes were poorly evaluated. The changes of gastritis were demonstrated as increased enhancement of the gastric wall. J. Magn. Reson. Imaging 10:950-960, 1999.

Adenocarcinoma↗
PubMed2006

[Reconstructive jejuno-gastroplasty in the treatment of operated stomach disease].

The results of treatment of 205 patients with operated stomach disease were analyzed. Conservative therapy was effective in 71.7% patients. Surgical treatment was used in 58 (28.3%) patients. Reoperation was performed less than a year after primary surgery in 5.2% patients, 1 to 3 years later -- in 41.4%, 3 to 5 years -- in 36.2%, more than 5 years later - in 17.2% patients. Early after operation complications were observed in 24.1% patients. Clinical and device examinations demonstrate that surgical reconstruction significantly reduces intensity of pathological symptoms in all the patients.

Adult↗
PubMed1982

[Experience in using thermography in the complex diagnosis of stomach diseases and an assessment of the effectiveness of their treatment].

On the basis of analysis of data of thermovision investigations of patients with gastritis, ulcerous disease of the stomach and duodenum, polyposis and carcinoma of the stomach, following gastric resection and vagotomy, the author has established characteristic and differential symptoms of the diseases in question. Advantages of the method for diagnosis of complications after resection of the stomach and for the assessment of results of the treatment are shown.

Chronic Disease↗